Fiduciary Trust’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $939K | Hold |
136,555
| – | – | 0.01% | 413 |
|
|
2025
Q1 | $393K | Hold |
136,555
| – | – | 0.01% | 583 |
|
|
2024
Q4 | $642K | Hold |
136,555
| – | – | 0.01% | 444 |
|
|
2024
Q3 | $488K | Hold |
136,555
| – | – | 0.01% | 474 |
|
|
2024
Q2 | $847K | Hold |
136,555
| – | – | 0.01% | 366 |
|
|
2024
Q1 | $1.29M | Hold |
136,555
| – | – | 0.02% | 304 |
|
|
2023
Q4 | $922K | Hold |
136,555
| – | – | 0.02% | 350 |
|
|
2023
Q3 | $606K | Hold |
136,555
| – | – | 0.01% | 399 |
|
|
2023
Q2 | $451K | Hold |
136,555
| – | – | 0.01% | 464 |
|
|
2023
Q1 | $389K | Hold |
136,555
| – | – | 0.01% | 491 |
|
|
2022
Q4 | $994K | Buy |
136,555
+4,083
| +3% | +$29.7K | 0.02% | 339 |
|
|
2022
Q3 | $1.07M | Hold |
132,472
| – | – | 0.02% | 309 |
|
|
2022
Q2 | $649K | Hold |
132,472
| – | – | 0.01% | 398 |
|
|
2022
Q1 | $3.13M | Hold |
132,472
| – | – | 0.06% | 200 |
|
|
2021
Q4 | $2.34M | Buy |
132,472
+3,257
| +3% | +$57.6K | 0.04% | 232 |
|
|
2021
Q3 | $3.65M | Buy |
129,215
+3,216
| +3% | +$90.7K | 0.06% | 186 |
|
|
2021
Q2 | $1.32M | Buy |
125,999
+1,000
| +0.8% | +$10.5K | 0.03% | 294 |
|
|
2021
Q1 | $1.47M | Hold |
124,999
| – | – | 0.03% | 273 |
|
|
2020
Q4 | $1.46M | Hold |
124,999
| – | – | 0.03% | 274 |
|
|
2020
Q3 | $991K | Hold |
124,999
| – | – | 0.02% | 294 |
|
|
2020
Q2 | $2.29M | Hold |
124,999
| – | – | 0.06% | 201 |
|
|
2020
Q1 | $1.49M | Buy |
124,999
+104,999
| +525% | +$1.25M | 0.04% | 221 |
|
|
2019
Q4 | $333K | Buy |
20,000
+10,000
| +100% | +$167K | 0.01% | 433 |
|
|
2019
Q3 | $66K | Buy |
+10,000
| New | +$66K | ﹤0.01% | 508 |
|